Events

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 12th Annual European Congress

The conference is schedule for October 24-27, 2009, in Paris, France.

ABS is an exhibitor at the conference and an event sponsor, and is also participating in the following workshops and presentations:

Sunday, October 25, 2009

WORKSHOPS - SESSION I

The role of patient registries in evidence development: similarities and differences between Europe and North America. (W6)

Discussion Leaders: Eric K Gemmen MA, Chris L Pashos PhD, Carl J Gibbons BsC, Christopher M. Blanchette PhD, MS, MA

POSTER PRESENTATIONS SESSION I

Development of serum tests for colorectal cancer screening. (PCN9)

Schiff L, Foster T, Junker F, Vogel-Ziebolz S, Pashos CL, Creeden J

Monday, October 26, 2009

POSTER PRESENTATIONS SESSION II

Financial impact of a novel preeclampsia diagnostic test vs. standard care: a decision-analytic modeling analysis from a German health care payer perspective. (PCV49)

Hadker N, Garg S, Costanzo C, Miller JD, van der Helm W, Foster T, Creeden J

Financial impact of a novel preeclampsia diagnostic test vs. standard care: a decision-analytic modeling analysis from a UK health care payer perspective. (PCV53)

Hadker N, Garg S, Costanzo C, Miller JD, van der Helm W, Foster T, Creeden J

Adherence to duloxetine therapy and health care costs among patients with fibromyalgia. (PSY9)

Chen SY, Boulanger L, Fraser K, Wu N, Zhao Y

Treating fibromyalgia with duloxetine: what is the association between average daily dose, medication adherence, and healthcare costs? (PSY100)

Wu N, Chen SY, Fraser K, Boulanger L, Zhao Y

Tuesday, October 27, 2009

POSTER PRESENTATIONS SESSION III

Time to opioid use and health care costs among patients with diabetic peripheral neuropathic pain who initiated duloxetine versus other treatments. (PDB19)

Zhao Y, Chen SY, Boulanger L, Fraser K, Wu N

Mental health costs incurred by patients diagnosed with major depressive disorder who do not respond to successive lines of treatment. (PMH36)
Svedsater H, Harrow B, Wu N, Ozer-Stillman I, Locklear JC

For more information, visit ISPOR or contact Julia Altman, ABS Director of Marketing, at (781) 372.6658 or julia.altman@abtbiopharma.com.